Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Electrophilic Aromatic Substitution: Sulfonation of Benzene01:22

Electrophilic Aromatic Substitution: Sulfonation of Benzene

Sulfonation of benzene is a reaction wherein benzene is treated with fuming sulfuric acid at room temperature to produce benzenesulfonic acid. Fuming sulfuric acid is a mixture of sulfur trioxide and concentrated sulfuric acid.
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PAPSS2-mediated BMPR1A sulfation in stromal cells regulating endometrial decidualization via autophagy.

Human reproduction (Oxford, England)·2026
Same author

Study on the rolling contact fatigue damage mechanism of welded rail joints in high-speed railways: based on a multiaxial fatigue damage model.

Scientific reports·2026
Same author

Dissection of the Genetic Basis of Maize Plant Architecture and Candidate Gene Mining Based on the MAGIC Population.

Genes·2026
Same author

PRGNet: a Parallel Residual Graph Network for enhanced drug-target binding affinity prediction.

BMC genomics·2026
Same author

Distribution of acetyl groups alters the properties of acetylated starch.

Carbohydrate polymers·2026
Same author

Enhancer hubs govern chromatin topology and Th17 cell identity.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 17, 2026

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
08:33

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

Published on: June 28, 2011

Accelerating SuFEx Reactions via Aryl Fluorosulfate Structural Engineering for Enhanced Covalent Targeted Cancer

Wenhui Gao1, Chuangchuang Zhang1, Daixi Li2

  • 1State Key Laboratory of Synergistic Chem-Bio Synthesis, Frontiers Science Center For Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

Angewandte Chemie (International Ed. in English)
|May 15, 2026
PubMed
Summary

Researchers enhanced covalent protein drug development by optimizing aryl fluorosulfate (SuFEx) warheads. A meta-fluoro substituted warhead showed increased reactivity, improving drug delivery and anti-tumor efficacy.

Keywords:
accelerated SuFEx reactionaryl fluorosulfate warheadscancer therapycovalent targetingstructural engineering

More Related Videos

Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers
07:26

Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers

Published on: February 28, 2019

Related Experiment Videos

Last Updated: May 17, 2026

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
08:33

Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

Published on: June 28, 2011

Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers
07:26

Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers

Published on: February 28, 2019

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Drug Discovery

Background:

  • Aryl fluorosulfate (SuFEx) warheads show promise for covalent protein drugs.
  • SuFEx reactivity is limited in complex protein environments.

Purpose of the Study:

  • To enhance SuFEx reactivity by modifying electronic and steric properties of warheads.
  • To develop novel covalent protein drugs with improved efficacy.

Main Methods:

  • Synthesis of maleimide-functionalized aryl fluorosulfate (MFS) with various substituents.
  • Conjugation of MFS warheads to Adnectin (EGFR-targeting protein).
  • Systematic investigation of SuFEx reactivity and covalent cross-linking efficiency.

Main Results:

  • The meta-fluoro (m-F) substituted MFS warhead exhibited the highest reactivity (3.5-fold increase).
  • m-F MFS-modified Adnectin enhanced intracellular accumulation (6.4-fold), tumor retention (3.0-fold), and anti-tumor efficiency (4.0-fold).

Conclusions:

  • Fine-tuning electronic and steric properties of warheads significantly enhances SuFEx reactivity.
  • Rational design of SuFEx-based warheads is crucial for developing effective covalent protein drugs.